Advanced Search
Now showing items 1-10 of 16
Reply: Dissociating angiotensin 1-9 anticardiovascular remodeling effects from those on blood pressure
(Lippincott Williams and Wilkins, 2014)
Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1-9) axis in experimental hypertension
(LIPPINCOTT WILLIAMS & WILKINS, 2011-04)
Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure
(MOSBY-ELSEVIER, 2011-05)
Novel therapies targeting cardioprotection and regeneration
(Bentham Science Publishers, 2017)